Clinical Trial Update: Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of oxaliplatin, capecitabine, and bevacizumab in older patients with colorectal cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Geriatric Oncology Consortium | Conditions: Colorectal Cancer, Neoplasm Metastasis | Phase 2 | Status: TERMINATED